Keywords: tanox, osteoporosis, deal, wyeth, usa-based, signed, agreements
Tanox in osteoporosis deal with Wyeth
Article | 17 November 2003
USA-based Tanox has signed agreements with Wyeth Pharmaceuticals todevelop new classes of drugs for the treatment of osteoporosis.
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- US Supreme Court says patent settlement can "sometimes" be illegal
- Negative US patent ruling for Novo Nordisk on Prandin
- Daiichi Sankyo files for Japanese approval of Prasugrel
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
